COVID-19 has done its best to halt our efforts, but scientific inquiry never stops. Dr Hartley’s lab has many focuses that overall relate to finding unknown lipid metabolism pathways related to re-myelination that we hope will shed light on new treatments for neurodegenerative disorders like MS.
Department of Chemistry – University of Kansas
